全球早洩治疗市场预测(2022-2028)
市场调查报告书
商品编码
1084467

全球早洩治疗市场预测(2022-2028)

Premature Ejaculation Treatment Market - Global Forecast, 2022 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球早洩治疗市场正受到新产品推出的增加、不健康的生活方式和忧郁症等各种因素导致的早洩增加以及荷尔蒙失调的推动。

本报告按市场概况、市场规模和预测、趋势、增长因素、抑制因素、药物类型、给药途径、剂型、分销渠道和地区对全球早洩治疗市场进行了调查条件等等。

目录

第 1 章调查目标/先决条件

    • 调查目的
    • 假设
    • 缩写

第 2 章市场展望

    • 报告说明
    • 市场定义和范围
    • 执行摘要
    • 市场细分:按药物类型
    • 市场细分:按管理途径
    • 市场细分:按剂型
    • 市场细分:按分销渠道
    • 市场细分:按地区
    • 连贯的机会图 (COM)

第 3 章市场动态、监管和趋势分析

    • 市场动态
    • 促进因素
    • 抑制因素
    • 市场机会
    • PEST 分析
    • 管道分析
    • 产品认证
    • 产品发布
    • 协作-收购
    • 波特五力分析

第 4 章全球早洩治疗市场:按药物类型(2017-2028 年)

    • 简介
    • 市场份额分析(2022 年和 2028 年)
    • 同比增长分析(2017-2028)
    • 细分趋势
    • 选择性血清素再摄取抑製剂 (SSRI)
    • 简介
    • 市场规模及预测,以及同比增长率(2017-2028)
    • 细分趋势
    • 达泊西汀
    • 其他
    • 5 型磷酸二酯□ (PDE5) 抑製剂
    • 简介
    • 市场规模及预测,以及同比增长率(2017-2028)
    • 细分趋势
    • 泽尔坦
    • 其他
    • 局部麻醉剂
    • 简介
    • 市场规模及预测,以及同比增长率(2017-2028)
    • 其他
    • 简介
    • 市场规模及预测,以及同比增长率(2017-2028)

第 5 章全球早洩治疗市场:按管理途径 (2017-2028)

    • 简介
    • 市场份额分析(2022 年和 2028 年)
    • 同比增长分析(2017-2028)
    • 细分趋势
    • 口服
    • 简介
    • 市场规模及预测,以及同比增长率(2017-2028)
    • 本地
    • 简介
    • 市场规模及预测,以及同比增长率(2017-2028)

第 6 章全球早洩治疗市场:剂型 (2017-2028)

    • 简介
    • 市场份额分析(2022 年和 2028 年)
    • 同比增长分析(2017-2028)
    • 细分趋势
    • 片剂
    • 简介
    • 市场规模及预测,以及同比增长率(2017-2028)
    • 喷雾
    • 简介
    • 市场规模及预测,以及同比增长率(2017-2028)
    • 其他
    • 简介
    • 市场规模及预测,以及同比增长率(2017-2028)

第 7 章全球早洩治疗市场:按分销渠道(2017-2028)

    • 简介
    • 市场份额分析(2022 年和 2028 年)
    • 同比增长分析(2017-2028)
    • 细分趋势
    • 医院
    • 简介
    • 市场规模及预测,以及同比增长率(2017-2028)
    • 网上药店
    • 简介
    • 市场规模及预测,以及同比增长率(2017-2028)
    • 零售药店
    • 简介
    • 市场规模及预测,以及同比增长率(2017-2028)

第 8 章全球早洩治疗市场:按地区(2017-2028 年)

    • 简介
    • 市场份额分析:按地区(2022 年和 2028 年)
    • 同比增长分析:按地区划分(2017-2028)
    • 北美
    • 市场规模和预测:按药物类型(2017-2028)
    • 市场规模和预测:按管理途径(2017-2028)
    • 市场规模及预测:按剂型(2017-2028)
    • 市场规模和预测:按分销渠道(2017-2028)
    • 市场规模和预测:按国家/地区分类(2017-2028)
    • 美国
    • 加拿大
    • 欧洲
    • 市场规模和预测:按药物类型(2017-2028)
    • 市场规模和预测:按管理途径(2017-2028)
    • 市场规模及预测:按剂型(2017-2028)
    • 市场规模和预测:按分销渠道(2017-2028)
    • 市场规模和预测:按国家/地区分类(2017-2028)
    • 英国
    • 德国
    • 义大利
    • 法国
    • 西班牙
    • 俄罗斯
    • 其他欧洲
    • 亚太地区
    • 市场规模和预测:按药物类型(2017-2028)
    • 市场规模和预测:按管理途径(2017-2028)
    • 市场规模及预测:按剂型(2017-2028)
    • 市场规模和预测:按分销渠道(2017-2028)
    • 市场规模和预测:按国家/地区分类(2017-2028)
    • 中国
    • 印度
    • 日本
    • 东盟
    • 澳大利亚
    • 韩国
    • 其他亚太地区
    • 拉丁美洲
    • 市场规模和预测:按药物类型(2017-2028)
    • 市场规模和预测:按管理途径(2017-2028)
    • 市场规模及预测:按剂型(2017-2028)
    • 市场规模和预测:按分销渠道(2017-2028)
    • 市场规模和预测:按国家/地区分类(2017-2028)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
    • 非洲
    • 市场规模和预测:按药物类型(2017-2028)
    • 市场规模和预测:按管理途径(2017-2028)
    • 市场规模及预测:按剂型(2017-2028)
    • 市场规模和预测:按分销渠道(2017-2028)
    • 市场规模和预测:按国家/地区分类(2017-2028)
    • 中非
    • 南非
    • 北非
    • 中东
    • 市场规模和预测:按药物类型(2017-2028)
    • 市场规模和预测:按管理途径(2017-2028)
    • 市场规模及预测:按剂型(2017-2028)
    • 市场规模和预测:按分销渠道(2017-2028)
    • 市场规模和预测:按国家/地区分类(2017-2028)
    • 海合会
    • 以色列
    • 其他中东

第 9 章竞争态势

    • 热图分析
    • 公司简介
    • Regent Pacific Group Limited
    • 公司简介
    • 产品组合
    • 主要发展
    • 财务表现
    • 战略
    • Menarini Group
    • 公司简介
    • 产品组合
    • 主要发展
    • 财务表现
    • 战略
    • Furirex Pharmaceuticals, Inc.
    • 公司简介
    • 产品组合
    • 主要发展
    • 财务表现
    • 战略
    • Absorption Pharmaceuticals, LLC
    • 公司简介
    • 产品组合
    • 主要发展
    • 财务表现
    • 战略
    • Ampio Pharmaceuticals, Inc.
    • 公司简介
    • 产品组合
    • 主要发展
    • 财务表现
    • 战略
    • Aytu BioScience
    • 公司简介
    • 产品组合
    • 主要发展
    • 财务表现
    • 战略
    • NeuroHealing Pharmaceuticals Inc.
    • 公司简介
    • 产品组合
    • 主要发展
    • 财务表现
    • 战略
    • Dong-A Pharmaceutical Co., Ltd.
    • 公司简介
    • 产品组合
    • 主要发展
    • 财务表现
    • 战略

第 10 章

    • 参考文献
    • 调查方法
    • 关于咨询和负责人
简介目录
Product Code: CMI1956

Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.

Market Dynamics

Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.

Key features of the study:

This report provides in-depth analysis of premature ejaculation treatment market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global premature ejaculation treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans

Key companies covered as a part of this study include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technological up-gradation, market expansion, and marketing tactics

The global premature ejaculation treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the premature ejaculation treatment market

Detailed Segmentation:

Global Premature Ejaculation Treatment Market, By Drug Type :

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

Global Premature Ejaculation Treatment Market, By Route of Administration:

Oral

Topical

Global Premature Ejaculation Treatment Market, By Dosage Form:

Pills

Spray

Others

Global Premature Ejaculation Treatment Market, By Distribution Channel:

Hospitals

Online Pharmacies

Retail Pharmacies

Global Premature Ejaculation Treatment Market, By Geography:

North America

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

By Route of Administration:

Oral

Topical

By Dosage Form

Pills

Spray

Others

By Distribution Channel

Hospitals

Online Pharmacies

Retail Pharmacies

By Country:

U.S.

Canada

Europe

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

By Route of Administration:

Oral

Topical

By Dosage Form

Pills

Spray

Others

By Distribution Channel

Hospitals

Online Pharmacies

Retail Pharmacies

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

By Route of Administration:

Oral

Topical

By Dosage Form

Pills

Spray

Others

By Distribution Channel

Hospitals

Online Pharmacies

Retail Pharmacies

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

By Route of Administration:

Oral

Topical

By Dosage Form

Pills

Spray

Others

By Distribution Channel

Hospitals

Online Pharmacies

Retail Pharmacies

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

By Route of Administration:

Oral

Topical

By Dosage Form

Pills

Spray

Others

By Distribution Channel

Hospitals

Online Pharmacies

Retail Pharmacies

By Country:

GCC

Israel

Rest of Middle East

Africa

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

By Route of Administration:

Oral

Topical

By Dosage Form

Pills

Spray

Others

By Distribution Channel

Hospitals

Online Pharmacies

Retail Pharmacies

By Country:

Central Africa

South Africa

North Africa

Company Profiles

Regent Pacific Group Limited *

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Menarini Group

Furiex Pharmaceuticals, Inc.

Absorption Pharmaceuticals, LLC

Ampio Pharmaceuticals, Inc.

Aytu BioScience

NeuroHealing Pharmaceuticals Inc.

Dong-A Pharmaceutical Co., Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Dosage Form
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • PEST Analysis
    • Pipeline Analysis
    • Product Approval
    • Product Launch
    • Collaboration-Acquisition
    • Porter's Five Forces Analysis

4. Global Premature Ejaculation Treatment Market, By Drug Type, 2017 - 2028 (US$ Bn)

    • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
    • Selective Serotonin Reuptake Inhibitors (SSRIs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Segment Trends
    • Dapoxetine
    • Others
    • Phosphodiesterase Type 5 (PDE5) Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Segment Trends
    • Zertane
    • Others
    • Topical Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

5. Global Premature Ejaculation Treatment Market, By Route of Administration, 2017 - 2028 (US$ Bn)

    • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
    • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

6. Global Premature Ejaculation Treatment Market, Dosage Form, 2017 - 2028 (US$ Bn)

    • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
    • Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Spray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

7. Global Premature Ejaculation Treatment Market, By Distribution Channel, 2017 - 2028 (US$ Bn)

    • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
    • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

8. Global Premature Ejaculation Treatment Market, By Region, 2017 - 2028 (US$ Bn)

    • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
    • North America
    • Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
    • U.S.
    • Canada
    • Europe
    • Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Africa
    • Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
    • Central Africa
    • South Africa
    • North Africa
    • Middle East
    • Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East

9. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
    • Regent Pacific Group Limited
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Menarini Group
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Furiex Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Absorption Pharmaceuticals, LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Ampio Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Aytu BioScience
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • NeuroHealing Pharmaceuticals Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Dong-A Pharmaceutical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

    • References
    • Research Methodology
    • About us and Sales Contact